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Abstract
Clinical trials are typically conducted over a population within a defined
time period in order to illuminate certain characteristics of a health issue or
disease process. Cross-sectional studies provide a snapshot of these disease
processes over a large number of people but do not allow us to model the
temporal nature of disease, which is essential for modelling detailed prognos-
tic predictions. Longitudinal studies on the other hand, are used to explore
how these processes develop over time in a number of people but can be ex-
pensive and time-consuming, and many studies only cover a relatively small
window within the disease process. This paper explores the application of
intelligent data analysis techniques for building reliable models of disease
progression from both cross-sectional and longitudinal studies. The aim is
to learn disease ‘trajectories’ from cross-sectional data by building realistic
trajectories from healthy patients to those with advanced disease. We focus
on exploring whether we can ‘calibrate’ models learnt from these trajecto-
ries with real longitudinal data using Baum-Welch re-estimation so that the
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dynamic parameters reflect the true underlying processes more closely. We
use Kullbaeck Liebler distance and Wilcoxon Rank metrics to assess how
calibration improves the models to better reflect the underlying dynamics.
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1. Introduction
Degenerative diseases such as cancer, Parkinson’s disease, and glaucoma
are characterised by a continuing deterioration to organs or tissues over time.
This monotonic increase in severity of symptoms is not always straightfor-
ward however. The rate can vary in a single patient during the course of their
disease so that sometimes rapid deterioration is observed and other times the
symptoms of the sufferer may stabilise (or even improve - for example when
medication is used). Interventions such as medication or surgery can make
a huge difference to quality of life and slow the process of disease progres-
sion but they rarely change the long term prognosis. The characteristics
of many degenerative diseases is therefore a general transition from healthy
to early onset to advanced stages. Longitudinal studies [1] measure clinical
variables from a number of people over time. Often, the results of multiple
tests are recorded, generating Multivariate Time-Series (MTS) data. This
is common for patients who have high risk indicators of disease where they
are monitored regularly prior to diagnosis. For example, patients with high
intra-ocular pressure are brought in to the clinic for visual field tests every
six months as they are at high risk of developing glaucoma. The advantages
of longitudinal data is that the temporal details of the disease progression
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can be determined. However, the data is often limited in terms of the co-
hort size, due to the expensive nature of the studies. Cross-sectional studies
record attributes (such as clinical test results and demographics) across a
sample of the population, thus providing a snapshot of a particular process
but without any measurement of progression of the process over time [2].
An advantage of cross sectional studies is that they capture the diversity
of a sample of the population and therefore the degree of variation in the
symptoms. The main disadvantage of such studies is that the progression of
disease are inherently temporal in nature and the time dimension is not cap-
tured. For longitudinal analysis, the patients are usually already identified
as being at risk and therefore, controls are usually not available and the early
stages of the disease may have been missed. While many data integration
techniques address representation heterogeneity where similar data is stored
in many different forms, as is common in bioinformatics data [26], they do
not attempt to combine variables from cross-section and longitudinal studies,
which is what is the focus of this paper. A related area of research, known as
panel analysis [21], involves trying to build models along both the temporal
dimension and the population dimension from panel studies. Another line of
research known as pooling has explored combining cross-sectional data with
time-series data [22]. Fitting trends through data [23] is a common approach
and is related in some ways to the idea of identifying a trajectory. Another
related area of research is sequence reconstruction. This involves trying to
find the best order for a particular set of data. Methods include the traveling-
salesman-problem approach that aims to minimize the distance between each
datum [24], and more recently, the use of PQ trees has been explored to en-
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code partial orderings in order to account for uncertainty in the data due to
elements such as noise [25]. Statistical process control [29, 28] has also been
explored for modelling clinical data including data with unknown temporal
ordering. Additionally, a resampling approach known as the Temporal Boot-
Strap (TBS) [5] has been developed that aims to build multiple trajectories
through cross sectional data in order to approximate genuine longitudinal
data. These ‘Pseudo Time-Series’ (PTS) can then be used to build approx-
imate temporal models for prediction. This approach has been extended in
order to cluster important stages in disease progression using Hidden Markov
Models (HMMs) [6]. However, the use of cross-sectional data alone will mean
that no genuine timestamps have been used to infer the models and so they
only capture an ordering without real temporal information.
In this paper, we explore how to minimise the expensive process of longi-
tudinal data collection by taking models that are learnt from cross-sectional
studies using pseudo temporal methods and ‘calibrating’ with limited lon-
gitudinal data. We do this calibration by using the Baum-Welch algorithm
to update stochastic models learnt from pseudo time-series so that the dy-
namic parameters better reflect the underlying process. Essentially, we are
integrating cross-sectional and longitudinal data to increase the temporal in-
formation and the diversity of data from a large population. Many data inte-
gration techniques address representation heterogeneity where similar data is
stored in many different forms, as is common in bioinformatics data [7]. Meta
Analysis, a popular approach [9], works by supplying a statistical framework
for identifying significant results over a number of independent published
studies, and calculating the significance of all of the studies when they are
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brought together. However, it can be prone to publication bias where positive
results are more likely to be published and therefore skew the statistics.
In the next section we formally describe the construction of pseudo time-
series using the temporal bootstrap, the experimental set up for assessing
the calibration of models with longitudinal data, and the clinical data from
glaucoma patients that is used. In the results section, the added value of
calibrating pseudo time-series models is demonstrated on simulated data and
real clinical data. Finally a case study is explored using the longitudinal
glaucoma data and a cross-sectional glaucoma study before conclusions are
made.
2. Methods
2.1. Generating pseudo time-series
Let a dataset D be defined as a real valued matrix where m (rows) is
the number of samples - here patients - and n (columns) is the number of
variables - clinical test data. We define D(i) as the ith row of matrix D. The
vector C = [c1, c2, . . . , cm] represents defined classes, where each ci ∈ {0, 1}
corresponds to the sample i, ci = 0 represents that sample i is a healthy case,
and ci = 1 represents that sample i is a diseased case. These classifications
are based upon the diagnoses made by experts. We define a time-series as a
real valued T (row) by n (column) matrix where each row corresponds to an
observation measured over T time points. We say that if T (i) was observed
before T (j) then i < j.
We define a set of pseudo time-series indices as P = {p1, p2, ...pk} where
each pi is a T length vector where T > 0. We define pij as the jth element
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of pi and each pij ∈ {1, ..., m}. We define the function F (pi) = [pi1, . . . , piT ]
as creating a T by n matrix where each row of F (pi) = D(pij). A pseudo
time-series can be constructed from each pi using this operator. For example,
if a pseudo time-series index vector p1 = [3, 7, 2] then F (p1) is a matrix where
the first row is D(3), the second row is D(7) and the third row is D(2). The
corresponding class vector of each pseudo time-series generated by F (pi) is
given by G(pi) = [C(pi1), . . . , C(piT )].
To demonstrate this notation consider the following example:
Let the data matrix D be defined as:
D =
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Let the corresponding class vector be C = [c1, c2, c3, c4]. If P = p1, p2
where p1 = [1, 3, 1] and p2 = [2, 3, 1] then:
F (p1) =
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, G(p2) = [c2, c3, c1].
Building pseudo time-series involves plotting trajectories through cross-
sectional data based upon distances between each point using prior knowledge
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of healthy and disease states. These trajectories can then be used to build
temporal models such as Dynamic Bayesian Networks (DBNs) [10] and Hid-
den Markov Models (HMMs) to make forecasts [11]. The temporal bootstrap
involves resampling data from a cross-sectional study and repeatedly build-
ing trajectories through the samples in order to build more robust time-series
models. Each trajectory begins at a randomly selected datum from a healthy
individual and ends at a random datum classified as diseased. The trajectory
is determined by the shortest path of Euclidean distances between these two
points. The data is first standardised to a mean µ of zero and a standard
deviation σ of one as we found that this led to better HMM models. We use
the Floyd-Warshall algorithm [12], a well established algorithm used to find
the shortest path in a minimum spanning tree from the weighted graph. A
full description of the algorithm to generate pseudo time-series is shown in
Algorithm 1 below and appears in [5]. An example of pseudo time-series that
have been generated from cross-sectional data are shown in Figure 1 below.
Again, this was plotted on the first two components that were generated us-
ing multidimensional scaling.
2.2. The Experiments
We explore three sets of experiments that try to identify whether adding
a small number of longitudinal data samples to models learnt from cross-
sectional data (via the PTS approach outlined in Algorithm 1) improves
them: i) One on simulated cross-sectional data whereby models are inferred
using pseudo time-series and are compared to the original underlying time-
series model. ii) Another on real data from Visual field tests where patients
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Algorithm 1 PSEUDO TIME-SERIES ALGORITHM
Input: Cross section data D; class labels C, sample size T ; number of
pseudo time-series k
Standardise dataset D to µ = 0 and σ = 1
for i = 1 to k do
Uniformly randomly sample (with replacement) T row indices from D
to create di such that there is at least one healthy and one diseased class
(in C) corresponding to any of the indices in di
Uniformly randomly select a row index from di, start, from where 1 ≤
start ≤ T and an endpoint, end, where 1 ≤ end ≤ T where C(di, start)
represents a healthy class and C(di, end) represents a diseased class
Construct a TxT matrix, Wi, of Euclidean distances between each
D(dia) and D(dib) for all combinations of indices in di
Calculate the minimum spanning tree over the matrix MSTi
Order di to create d∗i based upon the shortest path between
D(di, start) and D(di, end) given the tree MSTi using the FloydWarshall
algorithm [21]
Add the ordered d∗i to the set of pseudo time-series P
end for
return A set P of k pseudo time-series
Algorithm 2 CALIBRATING PSEUDO TIME-SERIES MODELS WITH
LONGITUDINAL DATA
Input: Cross section data D; class labels C, Longitudinal Data E; sample
size T ; number of pseudo time-series k
Apply Algorithm 1 to generate a set P of k pseudo time-series
Run the Baum Welch algorithm until convergence to infer an Auto-
Regressive Hidden Markov Model, H , from P
Update H using the Baum Welch algorithm with E for j iterations
return A calibrated Autoregressive HMM
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Figure 1: Example PTS generated from TBS on Simulated Data
who are at high-risk of developing glaucoma undertake a psychophysical test
to identify damage to sectors of their vision. Here no true original model
is known but a comparison can be made between single sampled-points of
the time-series (to simulate a cross-section), and models learnt from the full
time-series. iii) Finally, we explore integrating real cross-sectional clinical
data with real longitudinal clinical data as a case study.
i) Simulated Data
Firstly, we explore the effect of updating models of cross-sectional data, built
using PTS, with relatively small numbers of real time-series to see if the
resulting models are improved. This involves the use of the Baum-Welch re-
estimation algorithm applied to a prior HMM. This is outlined in Algorithm
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2. Essentially we want to see if the limitations of pseudo time-series can be
overcome (due to there being no time-element) by calibrating them with real
time-series.
In detail, we generate time-series of length 30 from an AutoRegressive
HMM (ARHMM) to mimic typical biomedical longitudinal data (MTS in
Figure 2). We then randomly sample a single point from these series (CS
DATA) to mimic the cross-sectional sampling of a population. We reserve
50 ARHMM time-series for the calibration (Reserved MTS). We start with
500 cross-sectional samples as this was found to be a suitably large size to
generate good pseudo time-series and models in [5] and increment by 100 up
to 1500 (the size of some increasingly large biomedical cross-sectional stud-
ies). We use the Kulbaeck-Leibler distance [13] to explore how close a model
learnt from the cross-sectional data using the Temporal BootStrap (TBS) is
to the original generating model. Finally, we use a number of the reserved
time-series generated by the same ARHMM to update the pseudo time-series
models (using Algorithm 2) and explore how close new calibrated models are
to the original. Increments of 10 time-series were used as increments of this
size seemed to involve significant changes in the KL distances. We also in-
clude how good the model is when learnt solely from the time-series used to
calibrate the models.
ii) Clinical Test Data
We then apply a similar set of experiments with real clinical longitudinal data
of visual fields from 91 patient time-series (91 MTS VF DATA in Figure 4).
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Figure 2: Simulated Data Experimental Framework
The longitudinal data is from a study of 23 ocular hypertensive patients
(who eventually develop reproducible glaucomatous VF loss) from a longitu-
dinal study at Moorfields Eye Hospital. A total of 255 patients with ocular
hypertension (raised intraocular pressure, a major risk factor for glaucoma)
volunteered to take part in a randomized placebo-controlled trial of treat-
ment to prevent the onset of glaucoma [15]. Of these, a number developed
reproducible VFs loss, as judged by the same classification algorithm, over
a median period of six years. Subjects had several repeated clinical visits
(approximately every six months). Each VF point maps to one of six Nerve
Fibre Bundles (NFBs) where information from the retina leaves the eye and
travels to the visual cortex [17] (see Figure 4). We average each VF points
over their associated nerve fibre bundle to give 6 variables representing each
spatial region. As a result, the data contains six NFB variables and one class
variable.
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Figure 3: Spatial Distribution of the 6 Nerve Fibre Bundles over the Visual Field. X’s
Denote the Blindspot
We sample one VF test from each patient’s time-series to generate a cross-
sectional sample and generate pseudo time-series for learning a time-series
model (PTS). We then compare this model as well as ones learnt from a com-
bination of pseudo time-series and real time-series (Random 10/20 MTS) to
see how quickly we can learn models that are close to the original. This is
achieved by comparing these KL distances to the mean KL distance between
200 different ARHMMs learnt from the same original time-series (MEAN
VARIANCE in Figure 4). In other words, if we can learn models from the
sampled CS data that have similar KL distances to the general variation in
learning a model from the full time-series, then we assume that the models
are as close to one learnt from a full time-series.
iii) Clinical Data Integration
Finally, as a case study, we integrate the longitudinal data from the last ex-
periment with real cross-sectional data in order to explore how the population-
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Figure 4: VF Data Experimental Framework
distribution information (from the cross-sectional data) and the dynamics of
progression (from the longitudinal data) can be integrated successfully. The
cross-sectional study consists of VF tests for 162 people, representing an ex-
panded dataset that was used to evaluate the classification accuracy of an
optic nerve head imaging device [18]. In brief, there were 84 healthy subjects
and 78 patients with early glaucomatous VF loss. A full medical history was
taken and a detailed ocular examination performed. Subjects underwent
Humphrey VF testing with the 24-2 program [16]. The VF data for each
subject are classified into one of two classes: healthy or glaucomatous based
upon an established classification algorithm for the field test [16]. Again, the
VF data is averaged into 6 NFBs as with the longitudinal study.
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3. Results
3.1. Simulated Data Results
Figure 5 shows the results for learning PTS from cross-sectional samples
of varying sizes and either not calibrating, or calibrating with 20 time-series,
along with 95% confidence intervals.
Figure 5: KL distance for varying cross-sectional study sample sizes with no calibration
and with 20 longitudinal data samples for calibration.
The first obvious characteristic of these graphs is that calibrating does
indeed improve the quality of the models with KL distances that are closer
to the original generating ARHMM. This is not surprising seeing that there
is no genuine ‘time’ in the PTS generated from the cross-sectional data.
What is surprising, is that only a relatively small number of time-series are
needed to improve these models, especially when there are lots of samples
used from the cross-sectional data. This supports the results from previous
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studies that the PTS does find good-but-not-perfect models (limited by the
lack of real time-series) and that a small number of genuine time-series can
calibrate these models. This offers hope that expensive longitudinal studies
can be relatively small in size if combined with larger cross-sectional studies
that capture the general trajectories and the variability of disease progres-
sion within a population. With calibration from 10 time-series, there is a
steady decrease in KL distance as cross-sectional sample size increases where
more and more reliable PTS are constructed. When the sample size is 1500
we see a KL distance mean of 1.70 ± 0.16. Note that when 10 time-series
alone are used to learn the model we get a mean KL distance of 2.08 ± 0.26.
This shows that the PTS generated from the cross-sectional data improves
on models learnt from the time-series only by incorporating the variabil-
ity within a larger population captured in the cross-sectional data. With
calibration from 20 time-series we see a similar story, where increasing the
cross-sectional sample size, build better PTS and results in models that are
closer to the original. For 1500 in the cross-sectional sample we see a KL
distance of 1.48 ± 0.12. Note that when 20 time-series alone are used to
learn the model we get a mean KL distance of 1.78 ± 0.15. Again, it can be
seen that the PTS improves on time-series alone but that the integration of
both seems to generate the models that best reflect the underlying model.
We now explore the statistical significance of the differences between these
KL distances using the Wilcoxon Rank Comparison [19]. Figure 6 shows the
Wilcoxon Rank statistic comparing the KL distance between different mod-
els learnt using the different approaches.
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Figure 6: Wilcoxon rank comparison between KL distances to original (significant p values
are marked with an asterisk p<0.01)
An asterisk is used to denote significant p values (i.e. the models are
significantly different). First of all notice that there are many significant
values - implying that the difference between models learnt using the different
approaches are significant. The most important statistics are those that show
the models learnt with no calibration and only 500 cross-sectional data points
are significantly different to most other models (row 1), but when 1500 cross-
sectional data points are used the resulting model is much closer, only being
significantly different to the model learnt from 50 full time-series (row 4).
However, by calibrating these models we see improvement for 500 CS data
points. For 1500 datapoints all models are not significantly different from
the full 50 time-series, indicating that the PTS algorithm can find models
that are not significantly different from a model inferred from full time-series
data when sample size is high (though the uncalibrated model is significantly
different at the 10% level - p=0.064). The model calibrated with 20 time-
series (cs1500calib20) shows better improvement with a clearly insignificant
difference between the models learnt from the full time-series (p=0.728).
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3.2. Visual Field Data Results
We now explore the effect of calibrating PTS using the real Visual Field
time-series data described earlier. As we have no knowledge of the true un-
derlying model, we firstly compare the KL distance between models that are
repeatedly learnt from the original 91 patient time-series in order to get an
idea of general variance between models and to use this as a base-line. If
we can generate models using PTS approaches with a KL distance that is
not significantly greater than the general variance between different builds
of the model on the full data, then it suggests that the PTS models are of
a suitably similar quality to those learnt from the full time-series (note that
variance in repeated model builds on full data could be due to small sam-
ples). We then calculate the KL distance between a model learnt from the
sampled cross-section using the PTS approach and models learnt from the
original 91 time-series. We then incrementally add a number of randomly
selected real time-series to calibrate the PTS model to see if this improves
the KL distance. We do this in two ways: simply concatenating the data
(Concat), and also using the PTS as a prior which is updated with real time-
series using the BW algorithm in Algorithm 2 (BW calibrated). Finally we
calculate the KL distance between learning models using only the calibrat-
ing time-series to confirm that the PTS are indeed improving the resulting
models. The experiments are repeated 100 times to derive confidence inter-
vals on the KL distances. Figure 7 shows the results of these experiments.
Notice firstly that the KL distance between models that have been learnt
on the full 91 time-series are in the region of 80-90 with a small confidence
interval denoting a relatively small variance from one model learning to the
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Figure 7: KL results for VF data with 95% confidence intervals.
Figure 8: Wilcoxon rank siginificance (significant p values are marked with an asterisk
p<0.01)
next. The models that are learnt from the sampled cross-section using the
PTS approach are impressively close to the time-series models but distinctly
higher in KL distance (likely to be because we are lacking real temporal in-
formation). When 10 and 20 real time-series are used to calibrate the model,
however, we see further improvement in the KL distance resulting in models
that are demonstrably closer to the models learnt from all 91 time-series. The
updated models that go beyond simply concatenating data appear to per-
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form the best with the lowest KL scores. Finally, models that are learnt from
using the relatively small number of calibrating time-series only are clearly
worse with much higher distance and large confidence intervals. Looking at
the Wilcoxon Rank for significance as before, the important thing to notice in
Figure 9 is that nearly all of the models are indeed significantly worse than
the variation between models learnt on the full longitudinal dataset (sig-
nificant differences are marked with an asterisk) except for the PTS model
calibrated using the updating approach or concatenating with 20 real time-
series. This shows that we can learn models that are as good as the natural
variation between model building on the full longitudinal dataset by building
PTS and calibrating with only 10 real longitudinal samples if we correctly
balance the weighting of the cross-sectional PTS and real time-series. We
can also see that many of the inferior models are similar in terms of their
distances except for the very worst models (learnt from only 10 time-series)
which are different from the superior models which are both PTS models
that have been calibrated. To summarise, whilst the PTS approach alone
does indeed learn very good models, by updating these models with a small
number of real time-series we get models that are considerably closer to the
models learnt using all the time-series data that is available. What is more,
the Baum-Welch approach to updating improves upon a simply concatena-
tion of data. Note that almost all models are significantly different from the
general variance form learning the model from the full 91 time-series. The
only models that are not significantly different at the 1% level are the PTS
models updated with data using the Baum-Welch approach and the PTS
model that is updated with 20 time-series by concatenation.
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3.3. Case study: Integrating Visual Field Cross-section with Longitudinal
Data
We now explore the use of a real cross-sectional dataset for building a
PTS and calibrating with real longitudinal data. We apply the same pro-
cess as outlined in Figure 4 but using the cross-sectional study discussed in
methods, rather than sampling a cross-section from the longitudinal data.
Calculating the KL distance to the full longitudinal data model is not appli-
cable here as the cross-sectional study contains valuable information about
healthy individuals and the early stages of disease that are not found in the
longitudinal study. Therefore, a new gold-standard is required. For this we
use the model learnt from the full cross-sectional data (using the pseudo
time-series approach) but calibrated by the full longitudinal study. We then
explore how few patient time-series are required to get close this standard.
See Figure 9 for the results where it is clear that only a relatively small num-
ber of real MTS are required to get close to the gold-standard (≥30).
We also explore the parameters of the different models: PTS, MTS and
Calib. This includes the dynamic parameters for the underlying disease pro-
cess and the static distributions for each nerve fibre bundle given either a
healthy or a diseased diagnosis. These are shown in Figure 10 for the dy-
namic parameters (where we assume the longitudinal-only model as the gold-
standard) and in Figure 11 for the static parameters (where we assume the
larger cross-sectional-data-only model to be the gold-standard). Notice that
the cross-sectional-only model (learnt using the pseudo time-series approach
- PTS) has learnt distributions for the dynamic parameters that are surpris-
ingly close to the gold-standard (MTS) model, but that the probability of
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Figure 9: KL Distance to the model learnt from the real CS Data and calibrated with
the full real longitudinal data, for differing numbers of calibrating MTS - including 95%
confidence intervals
switching from healthy to glaucomatous is too high. The calibration of this
model with time-series (Calib) improves this distribution considerably with a
closer match to the gold-standard. The static parameters for each NFB show
that the model learnt from the full longitudinal study (MTS) is sometimes
very different from the full cross-sectional model (PTS) which is considered
the gold-standard for distributions over the different NFBs (distributions for
NFBs 1 and 2 in particular are very different with the gold-standard PTS
being biassed to low VF sensitivity, but the MTS biassed to higher VF sen-
sitivities). The calibrated model demonstrates a set of distributions that are
generally closer to the gold-standard. For example, NFBs 3, 4 and 6 are
much closer than the uncalibrated MTS model. NFB 5 shows a slight im-
provement in the distribution when the MTS is calibrated. Looking at the
spatial layout of these NFBs in Figure 3 it seems that the distributions that
are not easily learnt from the MTS data are those in the upper hemisphere
(NFBs 1 and 2). This is interesting in that it is often these where the early
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signs are glaucoma are first detected.
In summary, the calibrated model better represents the gold standard for
the dynamic parameters (learnt from the longitudinal data) and the static
parameters for each NFB (learnt from the cross-sectional data), though some
NFBs show better improvement than others.
Figure 10: Dynamic Parameters for hidden variable where we consider the MTS model
learnt from the longitudinal data as the gold standard
4. Conclusions
In this paper we have explored to what degree pseudo time-series, learnt
from building trajectories through a cross-sectional study, can be ‘calibrated’
by a relatively small number of real time-series data form a clinical longitu-
dinal study. The aim is to gain the advantage of both types of study - the
population diversity of symptoms at all stages of a disease process from cross-
sectional data; and the inherently temporal information of a disease process
from longitudinal data. We have demonstrated that a relatively small num-
ber of disease time-series can dramatically improve the quality of disease
model if the pseudo time-series has been constructed from a large enough
cross-sectional sample. This has been shown to be the case for simulated
data based upon a probabilistic model and real-world clinical data where the
resultant models are not significantly different to models learnt from large
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longitudinal studies. The approach is best suited to large cross-sectional
studies though we have shown that only a small number of longitudinal sam-
ples are necessary to achieve improvement. Data has to be standardised prior
to building the trajectories and the distance metrics used in this paper to
construct them are based upon real valued data. In order to deal with bi-
nary / discrete data which is also common in medical contexts, other metrics
could be explored such as the Jaccard index, kapp, and adjusted rand.
Sometimes it will be important to place constraints on the trajectories
generated by the pseudo time-series. For some datasets, our method could
potentially build impossible trajectories: For example, a trajectory could
be built that contains different patients with different antibodies. As these
should not change in an individual over time, it makes the trajectory unreal-
istic. Different mechanisms to constrain these trajectories will be important.
One way to do this could exploit more detailed clinical evaluation rather
than the simplistic labelling of healthy and post-diagnosis. For example,
sometimes severity of stages in a disease progression are available and these
can be used to guide the trajectory construction.
Pseudo time-series naturally model multiple endpoint analysis which is
an important topic in modelling disease progression [20]. Future work will
explore the explicit understanding of these in terms of identifying subcate-
gories of disease (which they may well represent) and which we have already
started to explore [6]. We are also interested in exploring latent variables in
the context of discovered trajectories in order to identify subclasses similar
to [27] who use them in the context of extended mixed models.
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